Unlike those who took a chance on other novel approaches, they decided to focus on the recombinant protein vaccine — a type of vaccine that has repeatedly demonstrated its efficacy in preventing ...

Examples include the highly successful smallpox, measles, mumps, rubella, chicken pox and oral polio vaccines. Unlike inactivated, subunit or recombinant protein vaccines (such as those against ...

The recombinant protein vaccine, dubbed GSK3943104, did not meet the study’s primary efficacy objective. GSK added that the ...

Founded in 1987 in the US, Gale Smith – VP of vaccine development at Novavax – invented the technique of using insect cells for producing recombinant protein vaccines. A further milestone came ...

The Recombinant DNA Technology Market size is expected to be worth around USD 1288.5 Bn by 2032 from USD 786.7 Bn in 2023, growing at a CAGR of 5.8% As scientific and technological advancements ...